From left, CEO and Co-Founder Wensheng Fan and COO Niko Pagoulatos. [Photos: Spectral MD]
Spectral MD Holdings, founded over a decade ago, is a predictive analytics company focused on wound care treatment. It plans to delist from the AIM market and list on Nasdaq via a SPAC merger, operating as Spectral AI. The company’s AI-enabled FDA Breakthrough Designated DeepView platform uses AI algorithms and "difficult-to-duplicate" imaging technology to provide healing assessments.